Contrast-Enhanced Stereotactic Biopsy

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

October 13, 2023

Primary Completion Date

October 15, 2025

Study Completion Date

March 1, 2026

Conditions
Breast CancerBreast NeoplasmsBreast Cancer Female
Interventions
DIAGNOSTIC_TEST

Contrast Enhanced Stereotactic Biopsy

Stereotactic breast biopsy using CEM as targeting modality

Trial Locations (1)

6162BG

RECRUITING

Zuyderland Medical Center, Sittard

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Hologic, Inc.

INDUSTRY

lead

Zuyderland Medisch Centrum

OTHER

NCT06062992 - Contrast-Enhanced Stereotactic Biopsy | Biotech Hunter | Biotech Hunter